Search Results for 'Drug'

News
Himachal Pradesh suspends Wockhardt drug
Wed, Apr 23 2014. 08 04 PM

Himachal Pradesh suspends Wockhardt drug

State drug controller suspends manufacture, sale and distribution
Global pharma looks at be-first or get out strategy
Wed, Apr 23 2014. 12 42 PM

Global pharma looks at be-first or get out strategy

Generic-drug makers are buying up more profitable injectable and brand-name drugs in a bid to grow bigger than rivals
Glenmark to pay up to $25 million in damages to Abbott Labs
Wed, Apr 23 2014. 01 13 AM

Glenmark to pay up to $25 million in damages to Abbott Labs

The US court of appeals upheld a lower court’s order, saying Glenmark infringed Abbott’s patent on the drug by launching a cheaper copy of it in June 2010
GSK Pharma to lose oncology portfolio in India
Tue, Apr 22 2014. 11 41 PM

GSK Pharma to lose oncology portfolio in India

The oncology portfolio in India currently has three products
Pfizer agrees to $190 mn settlement over generic versions of epilepsy drug
Tue, Apr 22 2014. 11 37 AM

Pfizer agrees to $190 mn settlement over generic versions of epilepsy drug

Lawsuit alleged Pfizer delayed market entry of generic versions of its epilepsy drug Neurontin
Natco Pharma gains as much as 13% as Teva denied stay in patent fight
Mon, Apr 21 2014. 04 51 PM

Natco Pharma gains as much as 13% as Teva denied stay in patent fight

US Supreme Court denies Teva’s request to stay a ruling that favours generic competitors of Copaxone
Glenmark pulls 2,900 bottles of ulcer drug in US
Fri, Apr 18 2014. 12 57 PM

Glenmark pulls 2,900 bottles of ulcer drug in US

Glenmark is recalling the bottles of ranitidine after a foreign tablet was found in one of the bottles
New kind of trial aims to speed cancer drug development
Thu, Apr 17 2014. 10 41 AM

New kind of trial aims to speed cancer drug development

The aim is to quickly pinpoint medicines that can fight advanced lung cancer by targeting specific rare genetic mutations
Glenmark receives final approval for Lunesta copy
Wed, Apr 16 2014. 05 34 PM

Glenmark receives final approval for Lunesta copy

Glenmark Generics will immediately start selling its generic tablets of Lunesta, according to the company statement
Ranbaxy’s woes add $900 million in costs for heart drug
Tue, Apr 15 2014. 07 37 PM

Ranbaxy’s woes add $900 million in costs for heart drug

Ranbaxy — the only firm allowed to sell copies of Diovan— hasn’t been able to manufacture them after its 4 Indian factories failed US inspections

Did not find what you were looking for? Search again    
or try Advanced Search
  • Wed, Apr 23 2014. 05 42 PM
  • Wed, Apr 16 2014. 06 11 PM
Subscribe |  Contact Us  |  mint Code  |  Privacy policy  |  Terms of Use  |  Advertising  |  Mint Apps  |  About HT Media  |  Jobs
Contact Us
Copyright © 2014 HT Media All Rights Reserved